Quininib 是一种半胱氨酰白三烯 1 和 2 受体拮抗剂，对CysLT1R和CysLT2R的IC50分别为 1.2 和 52 μM。Quininib 是一种有效的斑马鱼眼发育性血管生成抑制剂。 Quininib可用于眼部新生血管病变的研究，可补充目前的抗 VEGF 生物制剂。
| 生物活性 | Quininib is acysteinyl leukotriene 1 and 2 receptorantagonist withIC50s of 1.2 and 52 μM forCysLT1RandCysLT2R, respectively. Quininib is a potent inhibitor of developmental angiogenesis in the zebrafish eye. Quininib can be used for the research of ocular neovascular pathologies and may complement current anti-VEGF biological agents[1]. |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
